Li, Ling
Name
Li, Ling
Loading...
4
0
5
0
false
Results 1-4 of 4
| Issue Date | Title | Author(s) | Type | |
|---|---|---|---|---|
| 1 | Jun-2018 | Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer | Shi, Xinan ; Li, Hongjian ; Shi, Anhua ; Yao, Hong ; Ke, Kun-Bin ; Dong, Chao ; Zhu, Ying ; Qin, Yi ; Ding, Ying ; He, Yan Hong ; Liu Xu ; Li, Ling ; Lei, Ling ; Hai, Qingshan ; Chen, Wei ; Prof. LEUNG Kwong Sak ; Wong, Man-Hon ; Kung, Hsiang-Fu ; Lin, Marie, Chia-mi | Peer Reviewed Journal Article |
| 2 | 2017 | In silico prediction and in vitro and in vivo validation of acaricide fluazuron as a potential inhibitor of FGFR3 and a candidate anticancer drug for bladder carcinoma | Ke, Kunbin ; Li, Hongjian ; Yao, Hong ; Shi, Xi-Nan ; Dong, Chao ; Zhu, Ying ; Liu, Xu ; Li, Ling ; Prof. LEUNG Kwong Sak ; Wong, Man-Hon ; Liu, Xiao-Dong ; Kung, Hsiang-fu ; Lin, Marie Chia-mi | Peer Reviewed Journal Article |
| 3 | 2015 | In silico identification and in vitro and in vivo validation of anti-psychotic drug fluspirilene as a potential CDK2 inhibitor and a candidate anti-cancer drug | Shi, Xi-Nan ; Li, Hongjian ; Yao, Hong ; Liu, Xu ; Li, Ling ; Prof. LEUNG Kwong Sak ; Kung, Hsiangfu ; Lu, Di ; Wong, Man-Hon ; Lin, Marie Chia-Mi | Peer Reviewed Journal Article |
| 4 | 2015 | Adapalene inhibits the activity of cyclin-dependent kinase 2 in colorectal carcinoma | Shi, Xi‑Nan ; Li, Hongjian ; Yao, Hong ; Liu, Xu ; Li, Ling ; Prof. LEUNG Kwong Sak ; Kung, Hsiang‑Fu ; Lin, Marie Chia‑Mi | Peer Reviewed Journal Article |